Background Indeterminate results are a recognised limitation of interferon-γ release assays (IGRA) in the diagnosis of latent tuberculosis (TB) infection (LTBI) and TB disease, especially in children. We investigated whether age and common co-morbidities were associated with IGRA performance in an unselected cohort of resettled refugees. Methods A retrospective cross-sectional study of refugees presenting for their post-resettlement health assessment during 2006 and 2007. Refugees were investigated for prevalent infectious diseases, including TB, and for common nutritional deficiencies and haematological abnormalities as part of standard clinical screening protocols. Tuberculosis screening was performed by IGRA; QuantiFERON-TB Gold in 2006 and QuantiFERON-TBGold In-Tube in 2007. Results Complete data were available on 1130 refugees, of whom 573 (51%) were children less than 17 years and 1041 (92%) were from sub-Saharan Africa. All individuals were HIV negative. A definitive IGRA result was obtained in 1004 (89%) refugees, 264 (26%) of which were positive; 256 (97%) had LTBI and 8 (3%) had TB disease. An indeterminate IGRA result was obtained in 126 (11%) refugees (all failed positive mitogen control). In multivariate analysis, younger age (linear OR = 0.93 [95% CI 0.91–0.95], P<0.001), iron deficiency anaemia (2.69 [1.51–4.80], P = 0.001), malaria infection (3.04 [1.51–6.09], P = 0.002), and helminth infection (2.26 [1.48–3.46], P<0.001), but not vitamin D deficiency or insufficiency, were associated with an indeterminate IGRA result. Conclusions Younger age and a number of common co-morbidities are significantly and independently associated with indeterminate IGRA results in resettled predominantly African refugees.
References
[1]
Glaziou P, Floyd K, Korenromp EL, Sismanidis C, Bierrenbach AL (2011) Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ 89: 573.582
[2]
McPherson ME, Leslie D, Sievers A, Patel M, Kelly H (2008) Epidemiology of laboratory confirmed tuberculosis in Victoria, 1990 to 2004. Commun Dis Intell 32: 237.241
[3]
Mant D, Mayon-White R (2007) Tuberculosis: think globally and act locally. Lancet 369: 1493.1494
[4]
Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B (2008) Paediatric tuberculosis. Lancet Infect Dis 8: 498.510
[5]
CDC (1989) A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 38: 269.272
[6]
(2002) National strategic plan for TB control in Australia beyond 2000. Commun Dis Intell 26: 238.241
[7]
Marks GB, Bai J, Simpson SE, Sullivan EA, Stewart GJ (2000) Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. American Journal of Respiratory & Critical Care Medicine 162: 1851.1854
[8]
Verver S, Bwire R, Borgdorff MW (2001) Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness. Int J Tuberc Lung Dis 5: 419.425
[9]
Jia Z, Cheng S, Jia X (2011) A Mathematical model for evaluating tuberculosis screening strategies. J Evid Based Med. 2011 Feb 5. doi: 10.1111/j.1756–5391.2011.01116.x. [Epub ahead of print].
[10]
Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761.776
[11]
Herrera V, Perry S, Parsonnet J, Banaei N (2011) Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 52: 1031.1037
[12]
Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D (2009) The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 28: 669.673
[13]
Bergamini BM, Losi M, Vaienti F, D’Amico R, Meccugni B (2009) Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 123: e419.424
[14]
Lucas M, Nicol P, McKinnon E, Whidborne R, Lucas A (2010) A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax 65: 442.448
[15]
Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G (2008) Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 22: 2471.2479
[16]
Connell TG, Tebruegge M, Ritz N, Bryant PA, Leslie D (2010) Indeterminate interferon-gamma release assay results in children. Pediatr Infect Dis J 29: 285.286
[17]
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010) Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10: 482.496
[18]
Potian JA, Rafi W, Bhatt K, McBride A, Gause WC (2011) Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J Exp Med 208: 1863.1874
[19]
Co DO, Hogan LH, Karman J, Heninger E, Vang S (2006) Interactions between T cells responding to concurrent mycobacterial and influenza infections. J Immunol 177: 8456.8465
[20]
Dhur A, Galan P, Hercberg S (1989) Iron status, immune capacity and resistance to infections. Comp Biochem Physiol A Comp Physiol 94: 11.19
[21]
Murray RJ, Davis JS, Burgner DP, Hansen-Knarhoi M, Krause V (2009) The Australasian Society for Infectious Diseases guidelines for the diagnosis, management and prevention of infections in recently arrived refugees: an abridged outline. Med J Aust 190: 421.425
[22]
Mutch RC, Cherian S, Nemba K, Geddes JS, Rutherford DM (2011) A Tertiary Paediatric Refugee Health Clinic in Western Australia: analysis of the first 1026 children. J Paediatr Child Health. (in press).
[23]
Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH (2008) An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One 3: e4030.
[24]
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911.1930
[25]
Schafer JL (1997) Analysis of incomplete multivariate data. London,: England: Chapman and Hall.
[26]
Connell TG, Curtis N, Ranganathan SC, Buttery JP (2006) Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 61: 616.620
[27]
Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N (2008) A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS One 3: e2624.
[28]
Cain KP, Haley CA, Armstrong LR, Garman KN, Wells CD (2007) Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 175: 75.79
[29]
Rowe J, Macaubas C, Monger T, Holt BJ, Harvey J (2001) Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine- specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function. J Infect Dis 184: 80.88
[30]
White GP, Watt PM, Holt BJ, Holt PG (2002) Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol 168: 2820.2827
[31]
Pearce EJ, C MK, Sun J, J JT, McKee AS (2004) Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 201: 117.126
[32]
Babu S, Bhat SQ, Kumar NP, Jayantasri S, Rukmani S (2009) Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis 200: 288.298
[33]
Elias D, Britton S, Aseffa A, Engers H, Akuffo H (2008) Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 26: 3897.3902
[34]
Cherian S, Burgner D (2007) Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees. Arch Dis Child 92: 983.986
[35]
Chih D, Heath C, Murray R (2006) Outpatient treatment of malaria in recently arrived African migrants. Med J Aust 185: 598.601
[36]
Enwere GC, Ota MO, Obaro SK (1999) The host response in malaria and depression of defence against tuberculosis. Ann Trop Med Parasitol 93: 669.678
[37]
Luong K, Nguyen LT (2011) Impact of vitamin D in the treatment of tuberculosis. Am J Med Sci 341: 493.498
[38]
Gauvain S (1948) Calciferol in the treatment of tuberculous galnds. Tubercle.
[39]
Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G (2000) Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355: 618.621
[40]
Martineau AR, Leandro AC, Anderson ST, Newton SM, Wilkinson KA (2009) Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 35: 1106.1112
[41]
Muller K, Odum N, Bendtzen K (1993) 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 35: 177.182
[42]
Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B (2007) A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176: 208.213
[43]
Rook GA (2009) Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 126: 3.11
